Strides to get $42 m from escrow account after winning arbitration on Agila sale
Strides Pharma Science and its wholly-owned subsidiary completed the sale to Mylan Laboratories and Mylan Institutional of Agila…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
The revival of pharma MSMEs
Effective implementation of the recently launched MSME Support and Outreach Programme could prove to be the catalyst for the…
Glenmark forays into branded dermatology segment in US
The branded portfolio for the US market will be developed and commercialised by Glenmark Therapeutics USA
European Commission okays Mylan, Biocon’s biosimilar of cancer drug
Ogivri is indicated for the treatment of patients with HER2 positive early breast cancer, metastatic breast cancer and metastatic…
Will quality trip or lift us up in 2019?
If 2018 was defined by Ayushman Bharat, what will define 2019?
As we wind up one year and gear up for the next, I wonder how CEOs…
Aptar Pharma to exhibit latest innovations in drug delivery devices at Pharmapack 2019 in Paris
The company will showcase two of their newest product launches, PureHale and QuickStart Injectables
The Pill House
Pill House or the pharmacy forms an integral part of the healthcare system. Pharmacies with well-organised practice can go a long…
Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil
Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its…
Pfizer’s cut-price version of Avastin wins EU panel greenlight
Pfizer's Zirabev is a cheaper version to Roche Holding's leading cancer drug Avastin